BELANOFF JOSEPH K
Director, Chief Executive Officer · 4 filings · Latest: May 29, 2026
CORCEPT THERAPEUTICS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CORT | BELANOFF JOSEPH K | Director, Chief Executive Officer | Jun 1, 2026 | Sale | $69.74 | 12,837 | $895.3K | 2,565,489 | |
CORT | BELANOFF JOSEPH K | — | Jun 1, 2026 | Proposed Sale | $69.49 | 12,837 | $892.0K | — | |
CORT | BELANOFF JOSEPH K | Director, Chief Executive Officer | May 1, 2026 | Sale | $50.10 | 40,000 | $2.0M | 2,878,326 | |
CORT | BELANOFF JOSEPH K | — | May 1, 2026 | Proposed Sale | $46.52 | 40,000 | $1.9M | — | |
CORT | BELANOFF JOSEPH K | Director, Chief Executive Officer | Mar 25, 2026 | Sale | $50.07 | 26,198 | $1.3M | 2,918,326 | |
CORT | BELANOFF JOSEPH K | — | Mar 25, 2026 | Proposed Sale | $33.82 | 40,000 | $1.4M | — | |
CORT | BELANOFF JOSEPH K | — | Dec 1, 2025 | Proposed Sale | $79.40 | 40,000 | $3.2M | — | |
CORT | BELANOFF JOSEPH K | — | Nov 3, 2025 | Proposed Sale | $73.47 | 40,000 | $2.9M | — | |
CORT | BELANOFF JOSEPH K | — | Oct 1, 2025 | Proposed Sale | $83.11 | 40,000 | $3.3M | — | |
CORT | BELANOFF JOSEPH K | — | Sep 2, 2025 | Proposed Sale | $69.72 | 40,000 | $2.8M | — | |
CORT | BELANOFF JOSEPH K | — | Aug 1, 2025 | Proposed Sale | $67.17 | 615 | $41.3K | — | |
CORT | BELANOFF JOSEPH K | — | Jul 17, 2025 | Proposed Sale | $72.85 | 40,000 | $2.9M | — | |
CORT | BELANOFF JOSEPH K | — | Jun 2, 2025 | Proposed Sale | $77.56 | 40,000 | $3.1M | — | |
CORT | BELANOFF JOSEPH K | — | May 2, 2025 | Proposed Sale | $71.48 | 350 | $25.0K | — | |
CORT | BELANOFF JOSEPH K | — | Apr 1, 2025 | Proposed Sale | $114.22 | 40,000 | $4.6M | — | |
CORT | BELANOFF JOSEPH K | — | Mar 3, 2025 | Proposed Sale | $60.58 | 40,000 | $2.4M | — |